We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Image: The partnership aims to broaden access to ultrasensitive blood-based testing for multiple myeloma and other hematologic malignancies (Image credit: 123RF)

Partnership Expands Ultrasensitive Blood-Based Diagnostics for Hematologic Malignancies

A new service integrating flow cytometry with single-cell genomics enables ultrasensitive blood detection of rare tumor clones. More...
16 Jun 2026
Image: Tempus will open source the Paige IMS, including its slide viewer, case management solution, and AI integration modules, providing a clinical-grade baseline platform for institutions worldwide (Photo courtesy of Tempus)

Open-Source Consortium Aims to Standardize Digital Pathology Workflows

A new open-source initiative now provides a clinical-grade platform and collaborative framework to advance standardization across institutions. More...
11 Jun 2026
Image: Alpha-1 antitrypsin deficiency (ADD) is a progressive genetic condition, a major inherited risk factor for COPD, and a cause of liver disease in children and adults (Image credit: Adobe Stock)

Genetic Testing Program Expands Detection of Alpha-1 Antitrypsin Deficiency

Grifols was named an inaugural industry sponsor of a program advancing routine, targeted Alpha-1 detection in patients with liver or lung disease. More...
10 Jun 2026
Image: Under the agreement, Natera will evaluate ctDNA from clinical trial samples collected in CytoDyn’s CLOVER Phase 2 study

Collaboration Advances ctDNA-Guided Development in Metastatic Colorectal Cancer

A personalized ctDNA-based MRD test assesses residual disease and response in metastatic CRC to inform leronlimab development. More...
08 Jun 2026
By integrating CLC’s business, Diazyme aims to strengthen its clinical chemistry offering and broaden its diagnostic solutions for laboratories.

Diazyme Laboratories Acquires Carolina Liquid Chemistries

The acquisition brings together Diazyme’s proprietary enzyme and immunoassay technologies with CLC’s cost-effective chemistry systems and reagents. More...
03 Jun 2026
Image: Through the collaboration with SouthGenetics, healthcare professionals across Latin America and the Caribbean will gain access to C2N’s Precivity portfolio of blood tests

Partnership Expands Access to Alzheimer’s Blood Tests in Latin America and Caribbean

C2N Diagnostics and SouthGenetics have partnered to expand access to Precivity blood tests for Alzheimer’s disease assessment across Latin America and the Caribbean. More...
02 Jun 2026
Photo courtesy of Shutterstock

Global Multiplex Assays Market Driven by High-Throughput Diagnostic Demand

Market growth is driven by demand for high-throughput diagnostics, multi-biomarker analysis, and precision medicine. More...
01 Jun 2026
Visit expo >
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Platelet Function Analyzer
PL-12
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.

In Other News



LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000 - 2026 Globetech Media.
All rights reserved.